1.
Spanoudakis E, Papoutselis M, Bazntiara I, Lamprianidou E, Kordella X, Tilkeridis C, Tsatalas C, Kotsianidis I. THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION. Mediterr J Hematol Infect Dis [Internet]. 2018Oct.27 [cited 2020Sep.21];10(1):e2018058. Available from: https://mjhid.org/index.php/mjhid/article/view/2018.058